Nanda, R., Liu, M. C., Yau, C., Shatsky, R., Pusztai, L., Wallace, A., . . . Esserman, L. J. (2020). Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial. JAMA Oncol.
Chicago Style CitationNanda, Rita, et al. "Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy On Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial." JAMA Oncol 2020.
Cita MLANanda, Rita, et al. "Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy On Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial." JAMA Oncol 2020.